Overview and Scope
Isotretinoin is a potent medication derived from vitamin A primarily used to treat severe acne, often providing significant improvement in skin conditions. They work by reducing oil production and promoting skin renewal, leading to clearer and healthier skin for many individuals. It’s usually prescribed when other treatments have failed, under strict medical supervision, and with careful consideration of potential risks and benefits.
Sizing and Forecast
The isotretinoin drugs market size has grown strongly in recent years. It will grow from $1.22 billion in 2023 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the prevalence of severe acne, the effectiveness of isotretinoin, marketing and awareness campaigns, regulatory approvals, and increased dermatology visits.
The isotretinoin drugs market size is expected to see strong growth in the next few years. It will grow to $1.60 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growing awareness and skincare trends, expansion in emerging markets, increasing incidence of acne, aging population, and focus on mental health and well-being. Major trends in the forecast period include research and development, technological advancements, generic drug innovations, improved formulations, and advances in dermatology.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/isotretinoin-drugs-global-market-report
Segmentation & Regional Insights
The isotretinoin drugs market covered in this report is segmented –
1) By Form: Capsules, Injection
2) By Indication Type: Severe Acne, Neuroblastoma, Cutaneous T-Cell Lymphoma, Harlequin Ichthyosis, Xeroderma Pigmentosum, Fibrodysplasia Ossificans Progressiva, Squamous Cell Skin Cancers, Other Indication Types
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies
North America was the largest region in the isotretinoin drugs market in 2023. The regions covered in the isotretinoin drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16095&type=smp
Major Driver Impacting Market Growth
Rising cases of skin cancer are expected to propel the growth of the isotretinoin drugs market going forward. Skin cancer is the uncontrolled growth of abnormal skin cells, typically caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Rising cases of skin cancer are primarily due to increased exposure to ultraviolet (UV) radiation from the sun and tanning beds, along with factors like ozone layer depletion and lifestyle changes leading to more outdoor activities without adequate sun protection. Isotretinoin drugs are used for preventing and treating certain types of skin cancer due to their ability to reduce the proliferation of abnormal skin cells. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there will be 108,270 reported cases of skin cancer, reflecting a 3.2% increase from the 104,930 cases reported in 2023. Therefore, rising cases of skin cancer will drive the growth of the isotretinoin drugs market.
Key Industry Players
Major companies operating in the isotretinoin drugs market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Hetero Drugs Ltd., Sun Pharmaceuticals Industries Limited, Intas Pharmaceuticals Ltd., Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc, Zydus Lifesciences Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd, Almirall LLC, Alembic Pharmaceuticals Ltd, Ajanta Pharma Ltd, Strides Pharma Science Limited, Wockhardt Ltd., Douglas Pharmaceuticals Limited, Chongqing Huapont Pharm Co. Ltd., Cipher Pharmaceuticals Inc., Vidhyasha Pharmaceuticals
The isotretinoin drugs market report table of contents includes:
1. Executive Summary
2. Isotretinoin Drugs Market Characteristics
3. Isotretinoin Drugs Market Trends And Strategies
4. Isotretinoin Drugs Market – Macro Economic Scenario
5. Global Isotretinoin Drugs Market Size and Growth
…
32. Global Isotretinoin Drugs Market Competitive Benchmarking
33. Global Isotretinoin Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Isotretinoin Drugs Market
35. Isotretinoin Drugs Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The regulatory compliance management software global market report 2024from The Business Research Company provides comprehensive…
The programming language global market report 2024from The Business Research Company provides comprehensive market statistics,…
The oral transmucosal drugs global market report 2024from The Business Research Company provides comprehensive market…
The morphine drugs global market report 2024from The Business Research Company provides comprehensive market statistics,…
Market Size - The melatonin supplements market size has grown rapidly in recent years. It will…
Market Size - The specimen validity testing market size has grown strongly in recent years. It…